Pulmonary Vascular Resistance
Showing 1 - 25 of >10,000
PV Loop and Pulmonary Hypertension
Recruiting
- Pulmonary Vascular Resistance Abnormality
- Measuring VA Coupling
-
San Francisco, California
- +1 more
Jul 29, 2022
PIMR and Pulmonary Vascular Disease
Recruiting
- Pulmonary Hypertension
- Pulmonary Index of Microcirculatory Resistance
- +2 more
-
Los Angeles, CaliforniaRonald Reagan UCLA Medical Center
Apr 24, 2023
The Role of the Pulmonary Vasculature in the Fontan Circulation
Recruiting
- Congenital Heart Disease
- +3 more
-
Groningen, NetherlandsUniversity Medical Center Groningen
Oct 19, 2021
Hypertension, Pulmonary, Cardiac Failure, Pulmonary Vascular Resistance Abnormality Trial in Athens (levosimendan at a dose of 3
Recruiting
- Hypertension, Pulmonary
- +2 more
- levosimendan at a dose of 3 mcg/kg
- +2 more
-
Athens, GreeceOnassis Cardiac Surgery Center
Feb 8, 2022
Hypertension, Pulmonary, Cardiac Failure, Pulmonary Vascular Resistance Abnormality Trial in Athens (levosimendan at a dose of 6
Recruiting
- Hypertension, Pulmonary
- +2 more
- levosimendan at a dose of 6 mcg/kg
- milrinone at a dose of 50 mcg/kg
-
Athens, GreeceOnassis Cardiac Surgery Center
Feb 8, 2022
ET1 Concentration, Metabolic Pathway Activation, and Pulmonary
Recruiting
- Single-ventricle
- +4 more
- Research Blood Sampling
-
Denver, ColoradoChildren's Hospital Colorado
Aug 16, 2021
Mitochondrial Substrate Utilization in the Diabetic Human Heart
Recruiting
- Heart Failure
- +4 more
-
Düsseldorf, GermanyUniversity-Hospital Düsseldorf Division of Cardiology, Pulmonary
Jul 14, 2023
Chronic Thromboembolic Pulmonary Hypertension, CTEPH Trial in Worldwide (Riociguat, Placebo, Pulmonary endarterectomy)
Terminated
- Chronic Thromboembolic Pulmonary Hypertension
- CTEPH
- Riociguat
- +2 more
-
La Jolla, California
- +3 more
May 31, 2021
Pulmonary Vascular Disorder, Primary Pulmonary Hypertension, Systemic Sclerosis Trial in Dresden, Heidelberg (Riociguat Oral
Recruiting
- Pulmonary Vascular Disorder
- +3 more
- Riociguat Oral Tablet
- Placebo
-
Dresden, Germany
- +1 more
Jan 26, 2023
Pulmonary Arterial Hypertension, Right Heart Failure, Right Ventricular Dysfunction Trial in Seattle (Valsartan 40 mg, Placebo)
Not yet recruiting
- Pulmonary Arterial Hypertension
- +3 more
- Valsartan 40 mg
- Placebo
-
Seattle, WashingtonUniversity of Washington Medical Center
Sep 13, 2023
Collapsed Lung, Hemodynamic Stability Trial (Alveolar recruitment maneuver, Nitric Oxide)
Not yet recruiting
- Collapsed Lung
- Hemodynamic Stability
- Alveolar recruitment maneuver
- Nitric Oxide
- (no location specified)
Oct 20, 2023
Patients With Kidney Transplantation
Recruiting
- Pulmonary Hypertension
- +2 more
- exercise echocardiography
-
Graz, AustriaMedical University of Graz, Department of Internal Medicine, Div
Nov 15, 2022
Pulmonary Vascular Disease, Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich
Active, not recruiting
- Pulmonary Vascular Disease
- +2 more
- Relocation from HA to LA
-
Zurich, SwitzerlandRespiratory Clinic, University Hospital of Zurich
Oct 17, 2023
Pulmonary Vascular Disorder, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich
Active, not recruiting
- Pulmonary Vascular Disorder
- +2 more
- Supplemental oxygen therapy
- Sham Oxygen therapy
-
Zurich, SwitzerlandUniversity Hospital Zürich
Oct 9, 2023
Chronic Thromboembolic Pulmonary Hypertension Trial in Beijing (Balloon pulmonary angioplasty)
Recruiting
- Chronic Thromboembolic Pulmonary Hypertension
- Balloon pulmonary angioplasty
-
Beijing, China
- +1 more
Dec 27, 2022
Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich
Active, not recruiting
- Pulmonary Vascular Disease
- +2 more
- Assessment without intervention at High altitude
- Relocation to sea level for 2 days
-
Zurich, SwitzerlandUniversity Hospital Zurich
Oct 2, 2023
Novel Index (PIMR) in PAH
Recruiting
- Pulmonary Hypertension
- Pulmonary Index of Microcirculatory Resistance
- Right Ventricle Index of Microcirculatory Resistance
-
Los Angeles, CaliforniaRonald Reagan UCLA Medical Center
Apr 17, 2023
Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich
Recruiting
- Pulmonary Vascular Disease
- +2 more
- Relocation to sea level
-
Zurich, SwitzerlandUniversity Hospital Zurich
Aug 9, 2023
Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zürich
Recruiting
- Pulmonary Vascular Disease
- +2 more
- 6-minute walk distance (6MWD) test
- 6-minute walk distance (6MWD) test with supplemental oxygen (3 l/min, nasal)
-
Zürich, SwitzerlandUniversity Hospital Zürich
Aug 18, 2023
Pulmonary Arterial Hypertension, Insulin Resistance Trial in Cleveland (Nutrition and Exercise)
Active, not recruiting
- Pulmonary Arterial Hypertension
- Insulin Resistance
- Nutrition and Exercise
-
Cleveland, OhioCleveland Clinic Foundation
May 6, 2022
Peripheral Arterial Disease Trial (Peripheral vascular flow reserve measurement)
Not yet recruiting
- Peripheral Arterial Disease
- Peripheral vascular flow reserve measurement
- (no location specified)
Aug 21, 2023
Pulmonary Vascular Dysfunction asCause of Persistent Exertional
Recruiting
- COVID-19
- pulmonary vascular dysfunction
- pulmonary vascular function
-
Giessen, GermanyNatascha Sommer
May 13, 2022